HC Andersen Capital Events 31/03: Meet the top management in ExpreS2ion Biotechnologies

Report this content

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.

ExpreS2ion Biotechnologies - Rights issue
From the 29th of March, ExpreS2ion will carry out a rights issue of units consisting of shares and warrants with preferential rights for existing shareholders. If fully subscribed, a rights issue that will raise about SEK 102m in cash before cost in the first round. Around 50% of the right issue is covered.  

In the event, we will focus on the details of the rights issue and attached warrant program, the use of the proceeds, and the options you have as an investor with preferential rights. There will be a live Q&A at the end. 

Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 1:31 PM 13-03-2023.

Friday 31st of March kl. 13:00 - 13:30


Sign up via. link


Disclaimer: HC Andersen Capital receives payment from the companies mentioned for a DigitalIR/Corporate Visibility agreement. The content is not buy or sell recommendations. 

 

Mie Halse
Head of Digital and Events
mie@hcandersencapital.dk
+45 28746640
 

HC Andersen Capital digitizes the relationship between listed companies and investors. We work long-term for companies that want more visibility in the market. #DemocraticIR - HC Andersen Capital works to democratize access to the financial market.

Subscribe